Following on from last week’s survey where members told us about the coronavirus impact on dementia research, the SDRC have created the COVID-19 Impact Report. This report outlines the severe impact that is already being felt. Researchers have told us about the effect across all aspects of their work, including job security, future prospects and scientific quality.

Read the SDRC COVID-19 Impact Report 

The main findings indicate the vast majority of respondents had had their research put on hold (70%) with only 28.3% believing that some form of extension to their work wouldn’t be required. Only 25% felt at this stage that the lock down has affected grant attainment. The reduced activity in the respondents own research pre-COVID has not been mitigated by moving their research work to COVID-19 related research that has only taken place in 14% of cases. After only four weeks of lockdown, 78.4% of respondents considered that the lockdown might or was already having an impact on their job security.

From the report, the SDRC Executive have put in place a strategy which involves passing report directly to the Scottish Government in addition our ongoing efforts to address the requests made by ECRs and raising these at the highest levels and will work on an ongoing basis to work through each of the challenges and potential solutions brought to our attention.

Following on from this report, we will re-run a similar survey in mid-July 2020 to gauge progress of SDRC interventions as well as further consequences of the coronavirus impact on dementia research. 

Please rest assured that the SDRC are doing all we can to support our members and research more widely at this time. To keep up to date with the work the SDRC are doing to help the ECR community, check out our blog or follow us on Twitter.

If would like to know more about the work of the SDRC, find out more here

 

 

Read more SDRC Latest

The launch of the SDRC Annual Report 2020/21

The SDRC Annual Report 2020/21, launched at the SDRC Annual Conference 2021 on Wednesday 16th June. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. Of course, it heavily features the impact COVID has...

Alzheimer Disease International Clinician Survey

This year Alzheimer's Disease International has commissioned McGill University, Montreal, Canada to produce this year's World Alzheimer Report on diagnosis, as well as the 2022 World Alzheimer Report on post-diagnostic support. The first of three surveys is now ready...

The launch of the SDRC Annual Report 2021/22

The SDRC Annual Report 2022, launched at the SDRC Annual Conference on Monday 9th May. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. It includes the updates from each of the SDRC Research Themes, as...

Research in the News: Football Heading and Dementia Risk

Researchers Glasgow Brain Injury Research Group (GBIRG) led by Associate Professor Willie Stewart, have published their findings reporting a link between a footballers' outfield position and neurodegenerative risk.  Taking place at the University of Glasgow, as part...

The launch of the SDRC Annual Report 2019/20

The SDRC Annual Report 2019/20, launched on Monday 20th April, outlines what is new in dementia and brain health research in Scotland in the past 12 months. Once again, we are able to show the truly amazing quantity, quality and diversity of research happening...

The launch of the SDRC Annual Report 2022/23

The SDRC Annual Report 2023, launched at the SDRC Annual Conference on Tuesday 25th April 2023. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. It includes the updates from each of the SDRC Research...

New SDRC Executive Committee Member: Dr Tom Russ

Following our recent SDRC Executive Committee election, we have seven new researchers join us.  The full list of members is available here. We are delighted to announce Dr Tom Russ as one of the newest members. Find out more about Tom below.  I trained in medicine and...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...

Life Sciences Event with the SDRC, SULSA, Brain Health Scotland & Alzheimer Scotland

On the 26-27 May 2022, the Scottish Universities Life Sciences Alliance (SULSA), the Scottish Dementia Research Consortium, Brain Health Scotland and Alzheimer Scotland hosted world leaders in Life Sciences at a summit at the University of St Andrews.  This two-day...

Scottish Neurological Research Fund 2021: Award Announcement

We have produced a report based on the findings of how COVID-19 has impacted our members’ research- with particular focus on ECRs